By: Editorial Staff
Date: June 30, 2026
For millions of individuals worldwide, the term "previvor" represents a unique intersection of medical awareness and psychological endurance. A previvor is an individual who is a survivor of a predisposition to cancer—typically identified through genetic testing—but who has not yet developed the disease. Despite the life-saving potential of early intervention and high-risk monitoring, the psychological toll of living in a state of "pre-cancer" is profound, often isolating, and significantly under-addressed within the broader mental health landscape.
Laura Schneebaum, LMHC-D, LPC, NCC, a specialist in the psychological treatment of individuals with hereditary cancer risks, recently highlighted a critical gap in professional care: the systemic failure of the mental health community to acknowledge the distinct, often invisible, struggles faced by this population.
Main Facts: The Silent Burden of Previvors
The core challenge for a previvor is the "waiting game." Unlike a cancer survivor who is navigating the aftermath of treatment, a previvor is navigating the anticipation of a potential future diagnosis. This distinction creates a unique set of stressors:
- Anticipatory Anxiety: The constant fear of the "next scan" or the next genetic screening result.
- The Burden of Choice: Previvors are often faced with life-altering medical decisions, such as prophylactic surgeries (e.g., mastectomies or oophorectomies) or rigorous surveillance protocols.
- Invisible Illness: Because they have not been diagnosed with cancer, their distress is often minimized by friends, family, and sometimes even medical providers who may view them as "healthy."
- Genetic Legacy: Many previvors grapple with feelings of guilt or anxiety regarding the transmission of genetic risks to their children or the history of their parents’ diagnoses.
Schneebaum notes that while clinical protocols for physical monitoring are well-established, the psychological roadmap for those who test positive for mutations like BRCA1 or BRCA2 is frequently underdeveloped.
Chronology: The Evolution of Previvor Advocacy
The term "previvor" was coined by the organization FORCE (Facing Our Risk of Cancer Empowered) in the early 2000s, but it has only recently gained traction in the clinical mental health space.
- Early 2000s: The medical community begins to standardize genetic testing for hereditary breast and ovarian cancer (HBOC). Focus is strictly on medical management and surgery.
- 2010–2020: The rise of online support communities allows previvors to find one another. The term "previvor" becomes a cornerstone of identity, shifting the narrative from "patient-in-waiting" to "proactive individual."
- 2023–2025: Increased recognition of "scanxiety"—the intense stress before and during medical screenings. Mental health professionals begin to advocate for specialized counseling models.
- 2026: Leading voices like Laura Schneebaum call for a paradigm shift, urging mental health practitioners to move away from "one-size-fits-all" therapy and toward specialized, trauma-informed care for those at high hereditary risk.
Supporting Data: The Psychological Toll
Recent psychological research indicates that the prevalence of anxiety and depression among high-risk populations is significantly higher than in the general public. According to studies conducted by organizations like Sharsheret, the "Waiting Room" phenomenon—the emotional limbo between tests—can trigger symptoms indistinguishable from Post-Traumatic Stress Disorder (PTSD).
- Chronic Stress Levels: A significant percentage of high-risk individuals report that their preoccupation with health risks interferes with their ability to maintain professional and personal relationships.
- The Decision-Making Fatigue: Research shows that the process of deciding between intensive surveillance versus risk-reducing surgery creates a "decision conflict" that can lead to long-term psychological paralysis.
- Lack of Specialized Care: A survey of mental health providers revealed that fewer than 15% of therapists reported receiving specific training in the nuances of hereditary cancer and the previvor experience.
Official Responses and Clinical Perspectives
The medical community is beginning to acknowledge that physical health cannot be separated from emotional well-being. Organizations like Sharsheret have stepped into the void, providing specialized support systems that bridge the gap between clinical oncology and mental health.
In her professional capacity, Schneebaum emphasizes that the therapeutic approach must be tailored. "I don’t believe in one-size-fits-all solutions," she explains. Instead, she advocates for a four-pillared approach to care:
- Validation of the "Unseen": Therapists must explicitly acknowledge that the previvor’s anxiety is a rational response to a real threat, not a manifestation of irrational fear.
- Strategic Coping for "Scanxiety": Developing personalized protocols for the days surrounding medical screenings to help patients regain a sense of agency.
- Family Dynamic Navigation: Addressing the complex guilt and communication barriers that arise when multiple family members share the same genetic risk.
- Integration of Proactive Health: Reframing medical screenings not as a source of dread, but as a tool for empowerment and control.
Implications for the Future of Healthcare
The call to action from practitioners like Schneebaum suggests that the future of oncology care must be multidisciplinary. It is no longer enough to offer a genetic test and a list of surgeons. The standard of care must include:
1. Integration of Mental Health in Genetic Counseling
Genetic counselors should work in tandem with mental health professionals from the moment a positive genetic result is delivered. This prevents the "sink or swim" mentality that many previvors experience in the weeks following a diagnosis.
2. Standardized "Previvor" Support Networks
Organizations need to expand the reach of peer-support programs. Connecting a 30-year-old previvor with someone who has already navigated the path of prophylactic surgery provides a unique level of comfort that a therapist cannot provide alone.
3. Professional Education Reform
The mental health field must integrate modules on hereditary cancer into clinical training. Understanding the nuances of "previvorship"—the difference between genetic predisposition and active disease—is essential for providing effective, empathetic care.
4. Normalizing the "Waiting Room" Mentality
As noted by Sharsheret, the "Waiting Room" is a state of being, not just a physical location. Healthcare systems must invest in digital resources, such as specialized hotlines and online platforms, where individuals can access immediate, informed support during the acute phases of anxiety.
Conclusion: A New Standard of Care
The previvor experience is one of profound courage. By choosing to know their genetic risk, individuals are actively working to save their own lives. However, this courage does not make them immune to the psychological weight of their reality.
As the medical community continues to refine its approach to genetic medicine, the mental health community must keep pace. The work being done by professionals like Laura Schneebaum is a vital step toward ensuring that no previvor feels forced to navigate the "waiting room" of life alone. By validating their experiences, providing evidence-based coping strategies, and fostering a community of shared understanding, we can ensure that the previvor population receives the holistic care they deserve.
For those navigating the challenges of hereditary cancer or the anxiety of high-risk status, resources are available. Sharsheret provides tailored support for the "waiting room" of life, offering a bridge for those facing the unknown. For more information, visit Sharsheret’s Waiting Room.
This article is supported by the generous contributions of partners committed to the intersection of oncology and mental health, including AstraZeneca and Merck.
About the Author
